Literature DB >> 19191915

Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions.

Yoshiki Yanagawa1, Kazuya Iwabuchi, Kazunori Onoé.   

Abstract

Interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) double producer is found in a subpopulation of T regulatory type 1 (Tr1) and T helper type 1 (Th1) cells. Consequently, it is of interest how IL-10 and IFN-gamma influence the immune system. However, few studies have addressed the co-operative action of these 'immunosuppressive' and 'immunostimulatory' cytokines. Here, we examine the effect of IL-10 combined with IFN-gamma on dendritic cell (DC) functions. Murine bone marrow-derived conventional DCs were stimulated with IL-10 and/or IFN-gamma for 24 hr. Tumour necrosis factor-alpha and IL-12 p40 production by DCs treated with both IL-10 and IFN-gamma was significantly lower than that by DCs treated with IL-10 or IFN-gamma alone. Major histocompatibility complex class II expression on DCs treated with both cytokines was attenuated compared with that on DCs treated with either cytokine alone. In contrast, levels of inducible nitric oxide synthase and indoleamine 2,3-dioxygenase, which appear to suppress T-cell responses and promote tolerance, in DCs treated with both cytokines were higher than those in DCs treated with IL-10 or IFN-gamma alone. Simultaneous treatment with IL-10 and IFN-gamma significantly suppressed the ability of DCs to activate CD4+ T cells compared with treatment with either cytokine. Therefore, IL-10 and IFN-gamma co-operatively suppress the immunostimulatory functions of DCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19191915      PMCID: PMC2712103          DOI: 10.1111/j.1365-2567.2008.02986.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Cdc42 is not essential for filopodium formation, directed migration, cell polarization, and mitosis in fibroblastoid cells.

Authors:  Aleksandra Czuchra; Xunwei Wu; Hannelore Meyer; Jolanda van Hengel; Timm Schroeder; Robert Geffers; Klemens Rottner; Cord Brakebusch
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

2.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins.

Authors:  Xiaoyu Hu; Paul K Paik; Janice Chen; Anna Yarilina; Lisa Kockeritz; Theresa T Lu; James R Woodgett; Lionel B Ivashkiv
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

3.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

Authors:  Stephanie Dillon; Sudhanshu Agrawal; Kaustuv Banerjee; John Letterio; Timothy L Denning; Kyra Oswald-Richter; Deborah J Kasprowicz; Kathryn Kellar; Jeff Pare; Thomas van Dyke; Steven Ziegler; Derya Unutmaz; Bali Pulendran
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 4.  The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

Authors:  M K Gately; L M Renzetti; J Magram; A S Stern; L Adorini; U Gubler; D H Presky
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

5.  IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages.

Authors:  P Allavena; L Piemonti; D Longoni; S Bernasconi; A Stoppacciaro; L Ruco; A Mantovani
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

Review 6.  T(H)-17 cells in the circle of immunity and autoimmunity.

Authors:  Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2007-04       Impact factor: 25.606

7.  Effect of T helper 1 (Th1)/Th2 cytokine on chemokine-induced dendritic cell functions.

Authors:  Jonathan M Clingan; Yoshiki Yanagawa; Kazuya Iwabuchi; Kazunori Onoé
Journal:  Cell Immunol       Date:  2006-11-13       Impact factor: 4.868

8.  Induction of tolerance by IL-10-treated dendritic cells.

Authors:  K Steinbrink; M Wölfl; H Jonuleit; J Knop; A H Enk
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

9.  Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.

Authors:  P Kaliński; J H Schuitemaker; C M Hilkens; M L Kapsenberg
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

10.  A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice.

Authors:  C Li; I Corraliza; J Langhorne
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

View more
  23 in total

Review 1.  Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells.

Authors:  D P McCarthy; J Bryant; J P Galvin; S D Miller; X Luo
Journal:  Am J Transplant       Date:  2015-03-23       Impact factor: 8.086

2.  CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes.

Authors:  Rajesh Singh; Shailesh Singh; David E Briles; Dennis D Taub; Susan K Hollingshead; James W Lillard
Journal:  Vaccine       Date:  2011-12-14       Impact factor: 3.641

3.  Stem Cells from Human Exfoliated Deciduous Teeth Ameliorate Autistic-Like Behaviors of SHANK3 Mutant Beagle Dogs.

Authors:  Lu Zhao; Yuan Li; Xiaoxing Kou; Benchi Chen; Jing Cao; Jun Li; Jianqi Zhang; Heng Wang; Jianping Zhao; Songtao Shi
Journal:  Stem Cells Transl Med       Date:  2022-07-20       Impact factor: 7.655

4.  A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis.

Authors:  Feiyan Liu; Linda B S Aulin; Sebastiaan S A Kossen; Julius Cathalina; Marlotte Bremmer; Amanda C Foks; Piet H van der Graaf; Matthijs Moerland; Johan G C van Hasselt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-10-19       Impact factor: 2.410

5.  TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.

Authors:  Nasreen Vohra; Monique Verhaegen; Lisa Martin; Amy Mackay; Shari Pilon-Thomas
Journal:  Cancer Immunol Immunother       Date:  2010-05       Impact factor: 6.968

6.  An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function.

Authors:  Christabelle J Darcy; Joshua S Davis; Tonia Woodberry; Yvette R McNeil; Dianne P Stephens; Tsin W Yeo; Nicholas M Anstey
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

Review 7.  Kynurenines in CNS disease: regulation by inflammatory cytokines.

Authors:  Brian M Campbell; Erik Charych; Anna W Lee; Thomas Möller
Journal:  Front Neurosci       Date:  2014-02-06       Impact factor: 4.677

8.  Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.

Authors:  Ulrike Kaufmann; Maria Diedrichs-Möhring; Gerhild Wildner
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).

Authors:  Yan Li; Amanda R Eskelund; Hua Zhou; David P Budac; Connie Sánchez; Maria Gulinello
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

10.  Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial.

Authors:  Vincent Millischer; Matthias Heinzl; Anthi Faka; Michael Resl; Ada Trepci; Carmen Klammer; Margot Egger; Benjamin Dieplinger; Martin Clodi; Lilly Schwieler
Journal:  J Neuroinflammation       Date:  2021-07-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.